Physician practice solution certified for Meaningful Use Stage 2
CHICAGO, Sept. 3, 2013 /PRNewswire/ — Allscripts (NASDAQ: MDRX) announced today that Allscripts Professional™ Electronic Health Record (EHR) 13.0 is now generally available. The release of Allscripts Professional EHR 13.0 is part of the company’s ongoing client commitment to provide the tools needed to help them achieve Meaningful Use Stages 1 and 2.
“Allscripts Professional EHR 13.0 is a reflection of our unwavering commitment to our clients,” said Paul M. Black, President and Chief Executive Officer of Allscripts. “This new version of Professional is a more powerful and more complete solution, with exceptional function and features.”
Allscripts Professional EHR 13.0 was certified for meeting ONC 2014 Edition Standards & Certification Criteria set by the Certification Commission for Health Information Technology (CCHIT®). ONC 2014 certification supports both Stage 1 and Stage 2 Meaningful Use, requiring EHR solutions have the capabilities that clients need to meet their attestation goals and clinical measures.
Intuitive operation, improved billing capabilities and specialty-specific clinical content makes Allscripts Professional the solution of choice for solo practitioners as well as mid-sized, multispecialty practices. Allscripts Professional EHR 13.0 has a number of important enhancements and features, including:
- Meaningful Use Stage 2 Compliance: Allscripts Professional has achieved complete and modular ONC 2014 certification, confirming that Allscripts Professional has the capabilities required for current Meaningful Use Stage 1 criteria and future Stage 2 criteria.
- Patient Portal Integration: Allscripts Professional can send and receive secure messages with patients through full patient portal integration. Allscripts Professional is integrated with FollowMyHealth™ and Intuit Patient Portals, enabling messaging between patients and providers. Integration with a full patient portal is required for meeting Meaningful Use Stage 2 standards.
In addition, Allscripts Professional 13.0 also includes enhancements to core EHR functionality which can help clients increase user efficiency and improve day-to-day use, including the following capabilities:
- Bi-Directional Immunizations: Receive immunization data from state immunization registries that are capable of exchanging data with practices.
- Care Plans and Goals: Build care plans, set goals, track patient progress, and identify barriers through the core EHR solution.
- InfoButton Technology: Context sensitive patient education and referential decision support are now available through InfoButton technology.
To complement Allscripts Professional EHR 13.0, and to help position practices to attain Meaningful Use, Allscripts offers multiple service options:
- Remote Assessments are available for all stages of Meaningful Use: Stage one, year one; stage one, year two; and stage two.
- Onsite Consultative Services are also available, including Meaningful Use Attestation Readiness Validation, which features a comprehensive assessment of a practice’s needs for Meaningful Use readiness.
Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company’s Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2013 Allscripts Healthcare, LLC. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are either registered trademarks or trademarks of Allscripts Healthcare, LLC in the United States and/or other countries. All other trademarks are the property of their respective owners.
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that our current initiatives focused on product delivery, client experience, streamlining our cost structure, and financial performance may not be successful, which could result in declining demand for our products and services, including attrition among our existing customer base; the impact of the realignment of our sales and services organization; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risks that we will not achieve the strategic benefits of the merger with Eclipsys Corporation (Eclipsys) or our acquisition of dbMotion, Ltd. (dbMotion), or that the Allscripts products will not be integrated successfully with the Eclipsys and dbMotion products; competition within the industries in which we operate, including the risk that existing clients will switch to products of competitors; failure to maintain interoperability certification pursuant to the Health Information Technology for Economic and Clinical Health Act (HITECH), with resulting increases in development and other costs for us and possibly putting us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; any costs or customer losses we may incur relating to the standardization of our small office electronic health record and practice management systems that could adversely affect our results of operations; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; errors or similar problems in our software products or other product quality issues; the outcome of any legal proceeding that has been or may be instituted against us and others; compliance obligations under new and existing laws, regulations and industry initiatives, including new regulations relating to HIPAA/HITECH, increasing enforcement activity in respect of anti-bribery, fraud and abuse, privacy, and similar laws, and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the continued implementation and ongoing acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009, as well as elements of the Patient Protection and Affordable Care Act (aka health reform) which pertain to healthcare IT adoption, including uncertainty related to changes in reimbursement methodology and the shift to pay-for-outcomes; maintaining our intellectual property rights and litigation involving intellectual property rights; legislative, regulatory and economic developments; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; breach of data security by third parties and unauthorized access to patient health information by third parties resulting in enforcement actions, fines and other litigation. See our Annual Report on Form 10-K/10K-A for 2012 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.
SOURCE Allscripts Healthcare Solutions, Inc.
Investors: Seth Frank, 312-506-1213, email@example.com or Media: Claire Weingarden, 312-447-2442, firstname.lastname@example.org